Art
J-GLOBAL ID:201702250827302108   Reference number:17A0331889

Discussion of pazopanib therapy for recurrent and refractory soft tissue sarcoma

再発・難治性悪性軟部腫瘍に対するpazopanib治療の検討
Author (5):
Material:
Volume: 36  Issue:Page: 41-46  Publication year: Mar. 01, 2017 
JST Material Number: L2652A  ISSN: 0286-3677  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0331889&from=J-GLOBAL&jstjournalNo=L2652A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of musculoskeletal system  ,  Drug therapy(=pharmacotherapy)for tumors 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (9):
  • Clark MA, Fisher C, Judson I et al : Soft-tissue sarcomas in adults. N Engl J Med 2005 ; 353: 701-11.
  • Sleijfer S, Ray-Coquard I, Papai Z et al : Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma : a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 2009 ; 27 : 3126-32.
  • van der Graaf WT, Blay JY, Chawla SP et al : Pazopanib for metastatic soft-tissue sarcoma (PALETTE) : a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012 ; 379: 1879-86.
  • Heng DY, Bukowski RM : Anti-angiogenic targets in the treatment of advanced renal cell carcinoma. Curr Cancer Drug Targets 2008 ; 8 : 676-82.
  • Bukowski RM : Pazopanib : a multikinase inhibitor with activity in advanced renal cell carcinoma. Expert Rev Anticancer Ther 2010 ; 10 : 635-45.
more...
Terms in the title (3):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page